Hitomi Yamanaka
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Ribosome biogenesis as a potential therapeutic target in KRAS mutant colorectal cancer.
Journal: Nature communications
Published: May 29, 2024
Paneth-like cells produced from OLFM4+ stem cells support OLFM4+ stem cell growth in advanced colorectal cancer.
Journal: Communications biology
Published: November 15, 2022
Integration of human inspection and artificial intelligence-based morphological typing of patient-derived organoids reveals interpatient heterogeneity of colorectal cancer.
Journal: Cancer science
Published: December 24, 2021
A protocol for efficient CRISPR-Cas9-mediated knock-in in colorectal cancer patient-derived organoids.
Journal: STAR protocols
Published: September 29, 2021
Evaluation of the RAS signaling network in response to MEK inhibition using organoids derived from a familial adenomatous polyposis patient.
Journal: Scientific reports
Published: May 19, 2020
Comparative Analysis of Patient-Matched PDOs Revealed a Reduction in OLFM4-Associated Clusters in Metastatic Lesions in Colorectal Cancer.
Journal: Stem cell reports
Published: March 19, 2020
IFN/STAT signaling controls tumorigenesis and the drug response in colorectal cancer.
Journal: Cancer science
Published: November 14, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026